Invention Grant
- Patent Title: Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof
- Patent Title (中): 获得治疗有效量的造血前体细胞及其长期植入物的方法
-
Application No.: US12520699Application Date: 2007-12-23
-
Publication No.: US08455450B2Publication Date: 2013-06-04
- Inventor: Amnon Peled , Michal Begin , Katia Beider , Michal Abraham
- Applicant: Amnon Peled , Michal Begin , Katia Beider , Michal Abraham
- Applicant Address: IL Nes Ziona
- Assignee: Biokine Therapeutics Ltd.
- Current Assignee: Biokine Therapeutics Ltd.
- Current Assignee Address: IL Nes Ziona
- International Application: PCT/IL2007/001596 WO 20071223
- International Announcement: WO2008/075369 WO 20080626
- Main IPC: C07K7/08
- IPC: C07K7/08 ; A61P7/00 ; A61K38/10
Abstract:
The present invention is directed to novel therapeutic uses of T-140 analog peptides and compositions comprising same. Specifically, the invention provides compositions and methods useful for providing improved bone marrow transplantation and in the treatment of other conditions wherein bone marrow depletion or suppression is involved.
Public/Granted literature
- US20100166715A1 T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR BONE MARROW RECOVERY Public/Granted day:2010-07-01
Information query
